DOCS.NYSEDoximity, INC

Form 4: Doximity CFO Sells $2.67M in Stock via 10b5-1 Plan

Sentiment:

Insider Transaction Report


Doximity's Chief Financial Officer, Anna Bryson, executed a pre-planned sale of 40,000 Class A common shares for approximately $2.67 million after converting Class B shares.

Summary

  • Anna Bryson, Doximity's Chief Financial Officer, engaged in a series of transactions on August 26, 2025.
  • She exercised 40,000 stock options at an exercise price of $8.26 per share, acquiring 40,000 shares of Class B Common Stock.
  • Immediately following the option exercise, these 40,000 Class B Common Stock shares were converted into 40,000 shares of Class A Common Stock.
  • Subsequently, 40,000 shares of Class A Common Stock were sold at a weighted-average price of $66.7561 per share, totaling approximately $2,670,244.
  • The sale was conducted automatically under a Rule 10b5-1 trading plan adopted on May 27, 2025.
  • Following these transactions, Bryson beneficially owns 346,925 shares of Class A Common Stock and 247,268 unexercised stock options.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. While an executive sale can sometimes be viewed negatively, the pre-planned nature via a 10b5-1 plan mitigates concerns about insider information. It represents a planned liquidity event for compensation.

Positives

  • The sale was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public information.
  • The exercise of options and subsequent sale demonstrates the executive realizing value from previously granted equity compensation.

Negatives

  • A significant sale of shares by a key executive, even if pre-planned, could be perceived negatively by some investors as it reduces the executive's direct equity stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: May view the sale as a routine liquidity event for an executive, especially given the 10b5-1 plan. Could also be seen as a slight reduction in executive alignment if not balanced by other holdings.
  • Management: The CFO is realizing value from long-term equity compensation.

Key Dates

DateDescription
2021-02-01Start of 60-month vesting period for stock options.
2021-02-05Date stock options were granted.
2025-05-27Date Rule 10b5-1 trading plan was adopted by the Reporting Person.
2025-08-26Date of stock option exercise, conversion of Class B to Class A, and sale of Class A shares.
2025-08-27Date the Form 4 filing was signed.
2031-02-04Expiration date of the stock options.

Recommendation

hold

The filing details a routine, pre-planned insider transaction by the CFO, involving the exercise of options and subsequent sale of shares under a 10b5-1 plan. This type of transaction is generally not indicative of new fundamental information about the company's prospects. Therefore, it does not provide a basis for changing an existing investment thesis, warranting a 'hold' recommendation.

Keywords

Doximity, DOCS, Anna Bryson, CFO, Insider Trading, Form 4, Stock Sale, Option Exercise, 10b5-1 Plan, Class A Common Stock, Class B Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.